Cassava Sciences, Inc.SAVANASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | -68 | -89 |
| Operating Income | -33 | -80 | -106 |
| Net Income | -32 | -76 | -97 |
| EBITDA | -32 | -79 | -104 |
| EPS Diluted | -0.81 | -1.80 | -2.32 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 233 | 201 | 121 |
| Total Current Assets | 244 | 211 | 130 |
| Total Assets | 267 | 235 | 152 |
| Total Current Liabilities | 13 | 7 | 14 |
| Total Liabilities | 13 | 7 | 14 |
| Total Equity | 254 | 228 | 137 |
| Total Debt | 0 | 0 | 0 |
| Net Debt | -233 | -201 | -121 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -30 | -78 | -82 |
| Capital Expenditure | -22 | -3 | -0 |
| Free Cash Flow | -52 | -80 | -82 |
| Stock-Based Comp | 2 | 2 | 5 |
| Net Change in Cash | 140 | -32 | -80 |